Tag Archives: Amla (Phyllanthus emblica syn. Emblica officinalis

Amla Supplementation Improves Lipid Indices in Patients with Dyslipidemia

Dyslipidemia, which is characterized by abnormal levels of triglycerides (TGs), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and very-low-density lipoprotein (VLDL), is a major risk factor for developing atherosclerosis and other cardiovascular diseases (CVDs). Amla (Phyllanthus emblica syn. Emblica officinalis, Phyllanthaceae) fruit extracts have demonstrated beneficial effects on lipid profiles in animal models of dyslipidemia and in three

Read more

Aqueous Extract of Amla Improves Endothelial Function, Oxidative Stress, Inflammation Markers, and Lipid Levels in Patients with Metabolic Syndrome

The components of metabolic syndrome (MetS) include abdominal obesity, insulin resistance with or without glucose intolerance, dyslipidemia, and hypertension. Conditions promoting thrombosis and inflammation are also associated with MetS. These metabolic abnormalities can lead to endothelial dysfunction (ED), a predictor of cardiovascular disease, by affecting nitric oxide (NO) synthesis or degradation. Amla (Indian gooseberry; Phyllanthus emblica syn. Emblica officinalis, Phyllanthaceae) fruits, which are

Read more